Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00793598 · ClinicalTrials.gov registry record · Phase 1
CMX001 in Post-transplant Patients With BK Virus Viruria
A Phase 1 study, sponsored by Jazz Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 29
- Enrollment target
NCT00793598 is a Phase 1 study that has completed, run by Jazz Pharmaceuticals. The registered enrollment target is 29 participants.
The verdict
NCT00793598, a Phase 1 study, has completed, sponsored by Jazz Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 29 participants
- Enrollment target
Study Summary
This was a randomized, double-blind, multiple-dose placebo-controlled study of oral brincidofovir (BCV) in hematopoietic stem cell transplant and renal transplant recipients with BK virus viruria.
Interventions
- DRUG Placebo
- DRUG Brincidofovir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00793598
The ClinicalTrials.gov registry entry for NCT00793598 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jazz Pharmaceuticals, which has 128 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00793598 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00793598 about?
NCT00793598 is a clinical study titled "CMX001 in Post-transplant Patients With BK Virus Viruria". This was a randomized, double-blind, multiple-dose placebo-controlled study of oral brincidofovir (BCV) in hematopoietic stem cell transplant and renal transplant recipients with BK virus viruria.
What is the current status of trial NCT00793598?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2009-11. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00793598?
The interventions under investigation include: Placebo (DRUG), Brincidofovir (DRUG).
Who is sponsoring clinical trial NCT00793598?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.